Literature DB >> 8156232

Febrile neutropenia.

J Klastersky1.   

Abstract

Fever is associated with malignancy and is a common problem in cancer patients. Fever in the cancer patients is closely linked with infection, especially when the patient is granulocytopenic. When fever appears, a series of diagnostic and therapeutic measures must be taken even if precise knowledge of the cause of the infection is lacking. Fever can be caused by infection or by the cancer itself through tumor-related necrosis, hemorrhage or pyrogens. Infection is the more common cause, however. Bacterial and fungal sepsis can coexist and the bacteremia can overshadow the more difficult to determine fungal infection. For this reason it has become accepted practice to administer amphotericin B to granulocytopenic patients who remain febrile after a few days of broad-spectrum antimicrobial therapy and in whom no bacteria can be documented. Viral infection is rarely diagnosed in neutropenic patients without concomitant immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8156232     DOI: 10.1007/bf00366041

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  19 in total

Review 1.  Unusual etiologies of fever and their evaluation.

Authors:  S M Wolff; A S Fauci; D C Dale
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Fever of unexplained origin: report on 100 cases.

Authors:  R G PETERSDORF; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

Review 3.  From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel.

Authors: 
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

4.  Fever of unexplained origin in patients with cancer.

Authors:  J Klastersky; D Weerts; C Hensgens; L Debusscher
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

5.  Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

Authors:  P A Pizzo; K J Robichaud; R Wesley; J R Commers
Journal:  Medicine (Baltimore)       Date:  1982-05       Impact factor: 1.889

6.  Streptococcal and enterococcal bacteremia in patients with cancer.

Authors:  A Awada; P van der Auwera; F Meunier; D Daneau; J Klastersky
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

7.  A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

Authors:  G M Schmidt; D A Horak; J C Niland; S R Duncan; S J Forman; J A Zaia
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

8.  Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

Authors:  Thierry Calandra; J Klastersky; H Gaya; M P Glauser; F Meunier; S H Zinner
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

9.  Acyclovir prophylaxis of herpes-simplex-virus infections.

Authors:  R Saral; W H Burns; O L Laskin; G W Santos; P S Lietman
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

10.  Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.

Authors: 
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

View more
  2 in total

1.  Supportive Care Organization in France: a national in-depth survey among patients and oncologists.

Authors:  Florian Scotté; Christian Hervé; Pauline Leroy; Jean-Marc Tourani; René-Jean Bensadoun; Marie-Eve Bugat; Fadila Farsi; Nicolas Jovenin; Moïse Namer; Christophe Tournigand; Sophie Morin; Cloé Brami; Stéphane Oudard; Alexandre Saadi; Ivan Krakowski
Journal:  Support Care Cancer       Date:  2017-02-20       Impact factor: 3.603

2.  Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome.

Authors:  S al-Bahar; R Pandita; B N Dhabhar; E al-Bahar
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.